The loss of nuclear TDP-43 together with its cytoplasmic accumulation and phase transition into insoluble aggregates plays a central role in the pathogenesis of the ALS/FTD disease spectrum and other TDP-43 proteinopathies [10, 58, 59]. Here, TARDBP is linked to amyotrophic lateral sclerosis.